JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB266067

Human GNG4 knockout HEK-293T cell line

Be the first to review this product! Submit a review

|

(0 Publication)

GNG4 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and 2 bp deletion in exon 3 and 4 bp deletion in exon 3.

View Alternative Names

GNGT4, Guanine nucleotide-binding protein G(I)/G(S)/G(O) gamma-4 subunit

3 Images
Sanger Sequencing - Human GNG4 knockout HEK-293T cell line (AB266067)
  • Sanger seq

Unknown

Sanger Sequencing - Human GNG4 knockout HEK-293T cell line (AB266067)

Allele-2 : 2 bp deletion in exon 3.

Sanger Sequencing - Human GNG4 knockout HEK-293T cell line (AB266067)
  • Sanger seq

Unknown

Sanger Sequencing - Human GNG4 knockout HEK-293T cell line (AB266067)

Allele-1 : 4 bp deletion in exon3

Sanger Sequencing - Human GNG4 knockout HEK-293T cell line (AB266067)
  • Sanger seq

Unknown

Sanger Sequencing - Human GNG4 knockout HEK-293T cell line (AB266067)

Allele-3 : 1 bp insertion in exon 3.

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and 2 bp deletion in exon 3 and 4 bp deletion in exon 3

Product details

Recommended control: Human wild-type HEK293T cell line (ab255449). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266067-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266067 Human GNG4 knockout HEK-293T cell line", "number":"AB266067-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab266067-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab266067 Human GNG4 knockout HEK-293T cell line", "number":"AB266067-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
GNG4
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The G-protein gamma subunit 4 also known as GNG4 is a component of the heterotrimeric G-protein complex. It has a molecular mass of approximately 7.9 kDa. This protein is typically expressed in various tissues including the brain and spinal cord. Functionally GNG4 is involved in signal transduction processes by forming a complex with the G-protein beta subunit playing a critical role in transmitting signals from G-protein-coupled receptors (GPCRs) to downstream effectors.
Biological function summary

GNG4 participates in the modulation of intracellular signal pathways. It forms an integral part of the G-protein complex which includes another subunit known as GNB1. This complex is necessary for proper functioning of GPCR-mediated signaling. The G-protein complex influences various cellular responses by affecting ion channels enzymes and other intracellular pathways. The presence of GNG4 in neuronal tissues suggests its role in neurotransmission and the potential influence on neurologic function.

Pathways

GNG4 plays a role in the adenylyl cyclase signaling pathway and the phospholipase C pathway. In both pathways GNG4 together with GNB1 regulates the conversion of extracellular signals into intracellular actions. These actions include cyclic AMP production or calcium ion release which subsequently affect cellular activities. This involvement links GNG4 to various cellular processes by mediating inputs from diverse signals through its interaction with GPCR-related pathways.

GNG4 is associated with conditions such as neuropsychiatric disorders and cancer. The aberrant expression or mutation of GNG4 can disrupt normal signaling pathways contributing to disease pathology. In neuropsychiatric disorders GNG4 interacts with dopamine receptor pathways affecting dopaminergic signaling; this connection suggests a possible link to conditions like schizophrenia. In cancer altered GNG4 expression has been observed in some tumor types indicating its potential involvement in tumorigenesis through signaling pathways linked to other proteins such as Ras.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com